Cargando…
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
Non-small-cell lung cancer (NSCLC) is the third most common cancer that spreads to the bone, resulting in osteolytic lesions caused by hyperactivation of osteoclasts. Activating mutations in epidermal growth factor receptor-tyrosine kinase (EGF-TK) are frequently associated with NSCLC, and afatinib...
Autores principales: | Ihn, Hye Jung, Kim, Ju Ang, Bae, Yong Chul, Shin, Hong-In, Baek, Moon-Chang, Park, Eui Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422028/ https://www.ncbi.nlm.nih.gov/pubmed/28256196 http://dx.doi.org/10.5483/BMBRep.2017.50.3.223 |
Ejemplares similares
-
Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway
por: Ihn, Hye Jung, et al.
Publicado: (2017) -
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023) -
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation In Vitro through the Downregulation of c-Fos and NFATc1
por: Kim, Kiryeong, et al.
Publicado: (2018) -
Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway
por: Ihn, Hye Jung, et al.
Publicado: (2015) -
Protective Effect of Ciclopirox against Ovariectomy-Induced Bone Loss in Mice by Suppressing Osteoclast Formation and Function
por: Ihn, Hye Jung, et al.
Publicado: (2021)